
2022 V-RED Winners
Blog There’s something unique about the Vasculitis Foundation’s (VF’s) 2022 Recognizing Excellence in Diagnostics (V-RED) award program: We have two winners who tied for first

Blog There’s something unique about the Vasculitis Foundation’s (VF’s) 2022 Recognizing Excellence in Diagnostics (V-RED) award program: We have two winners who tied for first

Blog Nona is a nationally known advocate of healthcare reform and champion of seniors’ issues. Originally an academic who served on the faculties of several

Blog Vasculitis and ANCA Workshop | April 2022 | Dublin, Ireland As part of the 20th International Vasculitis and ANCA Workshop, our investigators examined changes

Blog Mohanad M. Elfishawi, MBBCh, MS, began his one-year Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship on January 1, 2022. Dr. Elfishawi will be

Blog Kinanah Yaseen, MD, was awarded the 2020 Vasculitis Clinical Research Consortium (VCRC)-Vasculitis Foundation (VF) Fellowship. She is currently a junior faculty member in the

Blog By Gary Salzman, MD (Edited by Nina Silberstein) A diagnosis of vasculitis changed my life, but I didn’t let it ruin it. Today, I’m

Blog Vasculitis Patient Engagement and Impact of Online Patient Support Group Meetings Patients living with a rare disease like vasculitis face significant physical and psychosocial

Blog Autoimmune diseases are complicated conditions that can impact many organ systems in a patient. Typical models of care with providers spread out in different

Blog The Vasculitis Foundation (VF) is pleased to announce an exciting new initiative: Vasculitis-Building Outcomes, Leading Discoveries (V-BOLD), which combines three of the VF’s most

Blog Kelly Liang, MD, and her twin sister, Kimberly Liang, MD, both joined the University of Kansas Medical Center (KUMC) in December 2021. Kelly is
People living with vasculitis rely on support, research, and connection every day.
Today only, your donation will be matched dollar-for-dollar, helping us reach more patients, fund critical research, and ensure no one faces vasculitis alone.